Clinical Trial Update: Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of gemcitabine plus carboplatin in elderly patients with non-small cell lung cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Hamamatsu University | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED